According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

If you have a higher A1C or if metformin alone is not enough to meet your A1C and blood sugar goals, your doctor may prescribe a combination of medications. Each type of diabetes medication can ...

Amycretin, a dual pathway, oral weight loss drug, was found to be safe and tolerable in a phase 1 study and led to weight loss of up to 13% in people with overweight and obesity.

Combination may offer a substitute to basal-bolus insulin in people with type 2 diabetes inadequately controlled with daily basal insulin.

Enfortumab vedotin showed a robust disease control rate in patients with urothelial cancer outside of a clinical trial, and ...

Jennifer Green, MD, of Duke University, explained that while CMS-negotiated drug prices under the Inflation Reduction Act (IRA) may not immediately lower patients' costs, they could improve access to ...

A Columbia University-led multicenter research effort called IndiPHARM: individual metabolome and exposome assessment for pharmaceutical optimization will develop a platform and monitoring system to ...

"EASD 2024: A COMBINEd approach for better diabetes management" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

EASD 2024 participants are looking for the hottest efficacy data to make predictions on the next trend in the metabolic space ...

The kidney health benefits of SGLT2 inhibitors extend to patient subgroups with chronic kidney disease (CKD) in combo with other conditions.

New weight-loss pills cause weight loss almost four times as fast as Ozempic and similar injectable treatments ...